Adriana Bajetto

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators.

Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators.

Journal: Cells

Published: February 24, 2026

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma.

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 16, 2025

Simple and Rapid Model to Generate Differentiated Endometrial Floating Organoids.

Simple and Rapid Model to Generate Differentiated Endometrial Floating Organoids.

Journal: Bio-protocol

Published: November 03, 2025

A floating endometrial organoid model recapitulates epithelial-stromal cell interactions in vitro.

A floating endometrial organoid model recapitulates epithelial-stromal cell interactions in vitro.

Journal: Experimental cell research

Published: March 14, 2025

Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets.

Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets.

Journal: Molecular therapy. Nucleic acids

Published: March 10, 2025

Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets.

Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets.

Journal: Expert opinion on therapeutic targets

Published: November 25, 2024

Ruta graveolens, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma Cells.

Ruta graveolens, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma Cells.

Journal: International journal of molecular sciences

Published: September 13, 2024

Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells.

Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells.

Journal: International immunopharmacology

Published: August 02, 2023

Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.

Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.

Journal: Neuro-oncology

Published: April 19, 2023

Patient's dermal fibroblasts as disease markers for visceral myopathy.

Patient's dermal fibroblasts as disease markers for visceral myopathy.

Journal: Biomaterials advances

Published: September 08, 2022

Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.

Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 03, 2021

Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects.

Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects.

Journal: Cancers

Published: March 17, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026